AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
21.89
-2.49 (-10.21%)
Dec 3, 2024, 1:42 PM EST - Market open
AnaptysBio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 666 | 569 | 881 | 961 | 588 | 441 | |
| Market Cap Growth | 112.20% | -35.39% | -8.28% | 63.38% | 33.35% | -74.16% | |
| Enterprise Value | 679 | 486 | 760 | 608 | 251 | 25 | |
| Last Close Price | 24.38 | 21.42 | 30.99 | 34.75 | 21.50 | 16.25 | |
| Forward PE | - | - | - | 16.86 | - | - | |
| PS Ratio | 11.69 | 33.18 | 85.65 | 15.21 | 7.84 | 55.11 | |
| PB Ratio | 8.79 | 6.46 | 3.36 | 2.70 | 1.48 | 1.09 | |
| P/TBV Ratio | 11.99 | 6.46 | 3.36 | 2.70 | 1.48 | 1.09 | |
| EV/Sales Ratio | 11.87 | 28.31 | 73.84 | 9.62 | 3.34 | 3.09 | |
| Debt / Equity Ratio | 4.35 | 3.73 | 1.24 | 0.76 | 0.00 | 0.01 | |
| Asset Turnover | 0.12 | 0.03 | 0.02 | 0.12 | 0.18 | 0.02 | |
| Quick Ratio | 10.08 | 10.62 | 16.99 | 34.10 | 19.86 | 12.67 | |
| Current Ratio | 10.23 | 10.87 | 17.16 | 34.40 | 20.01 | 12.79 | |
| Return on Equity (ROE) | -161.81% | -93.44% | -41.62% | -15.35% | -4.97% | -21.84% | |
| Return on Assets (ROA) | -17.85% | -18.47% | -11.16% | -6.70% | -3.50% | -14.22% | |
| Return on Capital (ROIC) | -19.43% | -19.58% | -11.52% | -6.92% | -3.71% | -14.89% | |
| Earnings Yield | -22.33% | -28.74% | -14.61% | -6.02% | -3.39% | -22.08% | |
| FCF Yield | -13.94% | -21.36% | -8.39% | -4.92% | -2.50% | -15.95% | |
| Buyback Yield / Dilution | -0.08% | 4.41% | -2.68% | -0.47% | -0.90% | -9.67% | |
| Total Shareholder Return | -0.08% | 4.41% | -2.68% | -0.47% | -0.90% | -9.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.